scholarly article | Q13442814 |
P819 | ADS bibcode | 2012PLoSO...732419P |
P356 | DOI | 10.1371/JOURNAL.PONE.0032419 |
P932 | PMC publication ID | 3293807 |
P698 | PubMed publication ID | 22403656 |
P5875 | ResearchGate publication ID | 221689535 |
P2093 | author name string | John H Wolfe | |
Ramona Rozen | |||
Michael K Parente | |||
Cassia N Cearley | |||
P2860 | cites work | Analysis of gene regulatory networks in the mammalian circadian rhythm | Q21563498 |
Gene ontology: tool for the unification of biology | Q23781406 | ||
Expression cloning of a functional glycoprotein ligand for P-selectin | Q24304912 | ||
Olfactory marker protein (OMP) gene deletion causes altered physiological activity of olfactory sensory neurons | Q24320122 | ||
A gene network regulating lysosomal biogenesis and function | Q24339409 | ||
Murine mucopolysaccharidosis type VII. Characterization of a mouse with beta-glucuronidase deficiency | Q24626591 | ||
Expression of the homeobox genes OTX2 and OTX1 in the early developing human brain | Q24631258 | ||
KEGG for representation and analysis of molecular networks involving diseases and drugs | Q24644514 | ||
Molecular dissection of reactive astrogliosis and glial scar formation | Q24646628 | ||
Autophagy and the ubiquitin-proteasome system: collaborators in neuroprotection | Q24650675 | ||
Genome-wide atlas of gene expression in the adult mouse brain | Q26253934 | ||
Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources | Q27860739 | ||
The DC-HIL/syndecan-4 pathway inhibits human allogeneic T-cell responses | Q28114771 | ||
Reversal of pathology in murine mucopolysaccharidosis type VII by somatic cell gene transfer | Q28115950 | ||
A critical role for the protein tyrosine phosphatase receptor type Z in functional recovery from demyelinating lesions | Q28204617 | ||
Characterization of the CLEAR network reveals an integrated control of cellular clearance pathways. | Q51547401 | ||
Abnormalities in neural progenitor cells in a dog model of lysosomal storage disease. | Q51899182 | ||
Defective FA2H leads to a novel form of neurodegeneration with brain iron accumulation (NBIA). | Q51899563 | ||
From wild wolf to domestic dog: gene expression changes in the brain. | Q54710402 | ||
Olfactory marker protein modulates primary olfactory axon overshooting in the olfactory bulb | Q57641854 | ||
Antigen-specific immunity and cross-priming by epithelial ovarian carcinoma-induced CD11b(+)Gr-1(+) cells | Q84126765 | ||
The impact of the extracellular matrix on inflammation | Q28294058 | ||
Early neurodegeneration progresses independently of microglial activation by heparan sulfate in the brain of mucopolysaccharidosis IIIB mice | Q28472880 | ||
Cloning and characterization of osteoactivin, a novel cDNA expressed in osteoblasts | Q28573446 | ||
Urotensin II modulates rapid eye movement sleep through activation of brainstem cholinergic neurons | Q28584202 | ||
Lgi4 promotes the proliferation and differentiation of glial lineage cells throughout the developing peripheral nervous system | Q28588175 | ||
A transcriptome database for astrocytes, neurons, and oligodendrocytes: a new resource for understanding brain development and function | Q29547320 | ||
Mechanisms underlying inflammation in neurodegeneration | Q29617977 | ||
TM4 microarray software suite | Q29618829 | ||
Mucopolysaccharidosis IIIB, a lysosomal storage disease, triggers a pathogenic CNS autoimmune response | Q30495848 | ||
Dissection of hippocampal dentate gyrus from adult mouse. | Q30890249 | ||
Sanfilippo syndrome type B, a lysosomal storage disease, is also a tauopathy | Q33439351 | ||
Common and uncommon pathogenic cascades in lysosomal storage diseases | Q33966917 | ||
Patterning the cranial neural crest: hindbrain segmentation and Hox gene plasticity | Q34185517 | ||
Beta glucuronidase deficiency: report of clinical, radiologic, and biochemical features of a new mucopolysaccharidosis | Q34205101 | ||
Activated microglia in cortex of mouse models of mucopolysaccharidoses I and IIIB | Q34762478 | ||
Amygdala-enriched genes identified by microarray technology are restricted to specific amygdaloid subnuclei | Q35871922 | ||
GeneTrail--advanced gene set enrichment analysis | Q35914072 | ||
Glycosaminoglycans and their proteoglycans: host-associated molecular patterns for initiation and modulation of inflammation | Q36361058 | ||
Role of the sulfation pattern of chondroitin sulfate in its biological activities and in the binding of growth factors | Q36713851 | ||
The role of astrocytes and complement system in neural plasticity. | Q36902271 | ||
Glia proinflammatory cytokine upregulation as a therapeutic target for neurodegenerative diseases: function-based and target-based discovery approaches | Q36902298 | ||
Role of OPG/RANKL/RANK axis on the vasculature | Q37070441 | ||
Neuropeptide interactions and REM sleep: a role for Urotensin II? | Q37135968 | ||
Proteomics of the lysosome | Q37196950 | ||
Regional and strain-specific gene expression mapping in the adult mouse brain | Q37271547 | ||
Immunomodulatory and anti-inflammatory effects of chondroitin sulphate | Q37310621 | ||
Lysosomal disorders: from storage to cellular damage | Q37359176 | ||
Pathogenic cascades in lysosomal disease-Why so complex? | Q37364596 | ||
Hox genes and segmentation of the hindbrain and axial skeleton | Q37540204 | ||
Review: the ubiquitin-proteasome system: contributions to cell death or survival in neurodegeneration. | Q37702453 | ||
Olfactory system: functional organization and involvement in neurodegenerative disease | Q37790556 | ||
The role of otx2 in adult mesencephalic-diencephalic dopaminergic neurons | Q37810501 | ||
Functions of Chondroitin Sulfate and Heparan Sulfate in the Developing Brain | Q37812566 | ||
Signaling pathways in reactive astrocytes, a genetic perspective | Q37828480 | ||
The stem cell potential of glia: lessons from reactive gliosis | Q37830315 | ||
Widespread gene delivery and structure-specific patterns of expression in the brain after intraventricular injections of neonatal mice with an adeno-associated virus vector | Q39611260 | ||
Urotensin II evokes neurotransmitter release from rat cerebrocortical slices | Q39969296 | ||
Innate and adaptive immune activation in the brain of MPS IIIB mouse model. | Q40033388 | ||
Somatic gene therapy for a neurodegenerative disease using microencapsulated recombinant cells | Q40841413 | ||
Cellular pathology of lysosomal storage disorders. | Q40870656 | ||
Neural progenitor cell engraftment corrects lysosomal storage throughout the MPS VII mouse brain | Q41358776 | ||
Relationship between olfactory function and olfactory neuronal population in C57BL6 mice injected intraperitoneally with 3‐methylindole | Q42792030 | ||
l-arginine:glycine amidinotransferase (AGAT) deficiency: clinical presentation and response to treatment in two patients with a novel mutation | Q42947826 | ||
Numerous transcriptional alterations in liver persist after short-term enzyme-replacement therapy in a murine model of mucopolysaccharidosis type VII. | Q43003656 | ||
Beta-glucuronidase mediated pathway essential for retinal pigment epithelial degradation of glycosaminoglycans. Disease expression and in vitro disease correction using retroviral mediated cDNA transfer | Q43822158 | ||
OMP gene deletion results in an alteration in odorant-induced mucosal activity patterns | Q44548805 | ||
Klotho is a novel beta-glucuronidase capable of hydrolyzing steroid beta-glucuronides | Q44710659 | ||
Chondroitin sulfate disaccharide stimulates microglia to adopt a novel regulatory phenotype. | Q45864337 | ||
Neuroprotection of microglial conditioned medium on 6-hydroxydopamine-induced neuronal death: role of transforming growth factor beta-2. | Q46003783 | ||
Induction of early growth response-1 mediates microglia activation in vitro but is dispensable in vivo. | Q46051764 | ||
A sulfated disaccharide derived from chondroitin sulfate proteoglycan protects against inflammation-associated neurodegeneration | Q46882495 | ||
Accumulation of intracellular amyloid-beta peptide (A beta 1-40) in mucopolysaccharidosis brains. | Q48136972 | ||
Differential gene expression of aldolase C (ALDOC) and hypoxic adaptation in chickens | Q48150863 | ||
Variant clinical course of mucopolysaccharidosis type VII in two groups of mice carrying the same mutation. | Q48309593 | ||
Selective neurodegeneration in murine mucopolysaccharidosis VII is progressive and reversible | Q48439549 | ||
Otx2 controls identity and fate of glutamatergic progenitors of the thalamus by repressing GABAergic differentiation. | Q48515364 | ||
Immune system-related CD9 is expressed in mouse central nervous system myelin at a very late stage of myelination | Q48539694 | ||
Increased life span and correction of metabolic defects in murine mucopolysaccharidosis type VII after syngeneic bone marrow transplantation. | Q48612902 | ||
Neuropathology of murine mucopolysaccharidosis type VII. | Q48852047 | ||
Identification of new markers for neurodegeneration process in the mouse model of Sly disease as revealed by expression profiling of selected genes | Q49051031 | ||
P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
P6216 | copyright status | copyrighted | Q50423863 |
P433 | issue | 3 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | lysosomal storage disease | Q675010 |
P304 | page(s) | e32419 | |
P577 | publication date | 2012-03-05 | |
P1433 | published in | PLOS One | Q564954 |
P1476 | title | Dysregulation of gene expression in a lysosomal storage disease varies between brain regions implicating unexpected mechanisms of neuropathology | |
P478 | volume | 7 |
Q26853349 | Animal models for lysosomal storage disorders |
Q43671074 | Astrocytosis in infantile neuronal ceroid lipofuscinosis: friend or foe? |
Q35664978 | Bilateral single-site intracerebral injection of a nonpathogenic herpes simplex virus-1 vector decreases anxiogenic behavior in MPS VII mice |
Q33755372 | Brain RNA-Seq Profiling of the Mucopolysaccharidosis Type II Mouse Model |
Q41838423 | Circadian profiling in two mouse models of lysosomal storage disorders; Niemann Pick type-C and Sandhoff disease |
Q37705073 | Clinical neurogenetics: neuropathic lysosomal storage disorders |
Q36278875 | Diffusion tensor imaging and myelin composition analysis reveal abnormal myelination in corpus callosum of canine mucopolysaccharidosis I. |
Q27318087 | Evaluation of AAV-mediated Gene Therapy for Central Nervous System Disease in Canine Mucopolysaccharidosis VII. |
Q35623843 | Ex vivo gene therapy using patient iPSC-derived NSCs reverses pathology in the brain of a homologous mouse model |
Q89682420 | Genetic Base of Behavioral Disorders in Mucopolysaccharidoses: Transcriptomic Studies |
Q42100984 | High-resolution magnetic resonance microscopy and diffusion tensor imaging to assess brain structural abnormalities in the murine mucopolysaccharidosis VII model. |
Q35180647 | Identification of a biomarker in cerebrospinal fluid for neuronopathic forms of Gaucher disease |
Q27318642 | Immune-Mediated Inflammation May Contribute to the Pathogenesis of Cardiovascular Disease in Mucopolysaccharidosis Type I |
Q40217404 | Integrated analysis of proteome and transcriptome changes in the mucopolysaccharidosis type VII mouse hippocampus |
Q58571217 | Lysosomal and network alterations in human mucopolysaccharidosis type VII iPSC-derived neurons |
Q91591025 | Metabolomics profiling reveals profound metabolic impairments in mice and patients with Sandhoff disease |
Q26753109 | Moving towards effective therapeutic strategies for Neuronal Ceroid Lipofuscinosis |
Q59340084 | New treatments for the mucopolysaccharidoses: from pathophysiology to therapy |
Q33980271 | Oligodendrocyte loss during the disease course in a canine model of the lysosomal storage disease fucosidosis |
Q37238697 | Pathogenesis of mitral valve disease in mucopolysaccharidosis VII dogs. |
Q51758684 | The Aging of Iron Man. |
Q89697806 | Underestimated Aspect of Mucopolysaccharidosis Pathogenesis: Global Changes in Cellular Processes Revealed by Transcriptomic Studies |
Q53540627 | Validating glycoprotein non-metastatic melanoma B (gpNMB, osteoactivin), a new biomarker of Gaucher disease. |
Q91185200 | Variation among intact tissue samples reveals the core transcriptional features of human CNS cell classes |
Q37076523 | β-glucuronidase mRNA levels are correlated with gait and working memory in premutation females: understanding the role of FMR1 premutation alleles |
Search more.